Baylor Genetics Wins BioTech Breakthrough Award
19. November 2024 10:00 ET
|
Baylor Genetics
Baylor Genetics announced its selection as the 2024 winner of the “Overall Genomics Solution of the Year" from BioTech Breakthrough.
Baylor Genetics Named to Fast Company’s Best Workplaces for Innovators List
10. September 2024 10:45 ET
|
Baylor Genetics
HOUSTON, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, announced it has been named to Fast Company’s Best Workplaces for...
Baylor Genetics and Baylor College of Medicine Announce New Lab Agreement with Shared Commitment to Innovation and Rapid Implementation to get Critical Testing to Patients
05. August 2024 10:00 ET
|
Baylor Genetics
Baylor Genetics and the Department of Molecular and Human Genetics at Baylor College of Medicine have entered a new lab agreement.
Baylor Genetics Launches RNASeq Test for Whole Genome and Whole Exome Sequencing, Reduces Turnaround Times, Introduces Four New Genetic Analysis Panels
13. Mai 2024 09:00 ET
|
Baylor Genetics
Baylor Genetics today announced the availability of a new RNA sequencing test, RNAseq, for Whole Exome and Whole Genome Sequencing (WES/WGS).
Using AI to Improve Diagnosis of Rare Genetic Disorders
25. April 2024 09:19 ET
|
Baylor Genetics
Diagnosing rare Mendelian disorders is a labor-intensive task, even for experienced geneticists. Investigators at Baylor College of Medicine are trying to
Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Screening and More in 11 Presentations at ACMG 2024
04. März 2024 10:00 ET
|
Baylor Genetics
Researchers present abstracts and poster sessions showcasing research and clinical solutions.
Joint session planned with Illumina.
Baylor Genetics Chief Medical Officer Christine Eng, M.D., Shares Sequencing Approaches for Undiagnosed Patients at Precision Medicine World Conference 2024
23. Januar 2024 09:00 ET
|
Baylor Genetics
Showcase Presentation to Include Case Examples from NIH’s Undiagnosed Diseases Network (UDN)
Baylor Genetics Accelerates Growth, Combines Clinical and Scientific Expertise with Commercial Capabilities to Meet Increased Needs of Patients, Providers and Partners
03. Januar 2024 10:00 ET
|
Baylor Genetics
Company Expands Test Offerings, Lab Technology, and Customer-Centric Tools Rapid Comprehensive Whole Genome and Exome Sequencing, Disease-Specific Panels and Customizable Solutions Advance Diagnoses...
Baylor Genetics to Present Scientific Research Findings at Upcoming NORD, NSGC and ASHG Conferences
02. Oktober 2023 10:00 ET
|
Baylor Genetics
Baylor Genetics to present at three top genetic conferences on WES, WGS, carrier screening and non-invasive prenatal testing
Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays
12. September 2023 08:00 ET
|
Baylor Genetics
HOUSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced the availability of a new Neurodevelopmental...